Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline, Research Triangle Park, NC 22709, NDC 0173-0682-20.

Defective Delivery System: Elevated number of units with out of specification results for leak rate.

Recall #: D-0626-2017
Affected scope: 593,088 inhalers
Initiated: March 22, 2017

Compiled from official public sources by the publisher. · Updated September 2026

GlaxoSmithKline, LLC recalled Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered In… - a moderate-severity action.

Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered In… was recalled by GlaxoSmithKline, LLC in April 12, 2017. Reason: Defective Delivery System: Elevated number of units with out of specification results for leak rate.. Check the official notice for the remedy. Verify recall #D-0626-2017 with the FDA Drug before acting.

The recall

GlaxoSmithKline, LLC issued this moderate-severity FDA Drug recall-Defective Delivery System: Elevated number of units with out of specification results for leak rate..

Moderate
severity level: Class II
classification: April 12, 2017
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0626-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline, Research Triangle Park, NC 22709, NDC 0173-0682-20.

Reason for recall

Defective Delivery System: Elevated number of units with out of specification results for leak rate.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Ongoing
Recall number	D-0626-2017
Date reported	April 12, 2017
Date initiated	March 22, 2017
Recalling firm	GlaxoSmithKline, LLC
Firm location	Zebulon, NC
Affected scope	593,088 inhalers
Distribution	Nationwide in the USA and Puerto Rico

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0626-2017) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Defective Delivery System: Elevated number of units with out of specification results for leak rate.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on April 12, 2017. Severity: Moderate. Recall number: D-0626-2017.

Where was the recalled product distributed? ▼

Distribution: Nationwide in the USA and Puerto Rico.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Customatic Beds Recalls Adjustable Beds D… 2017-04-12 Kalbitor (ecallantide), 10mg/mL, packaged… 2017-04-12 Cotellic (cobimetinib) Tablets, 20 mg, 63… 2017-04-12 Nestle Butterfinger Peanut Butter Crisp C… 2017-04-12

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Nifedipine Extended-Release Tablets, 30 m… 2017-04-12 Adalat CC (nifedipine) Extended Release T… 2017-04-12 Adalat CC (nifedipine) Extended Release T… 2017-04-12 Nifedipine Extended-Release Tablets, 60 m… 2017-04-12

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported April 12, 2017. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026